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Abstract
While genetic and environmental factors and their interactions influence susceptibility to rheumatoid
arthritis (RA), causative genetic variants have not been identified. The purpose of the present study was
to assess the effects of covariates and genotype × sex interactions on the genome-wide association
analysis (GWAA) of RA using Genetic Analysis Workshop 16 Problem 1 data and a logistic regression
approach as implemented in PLINK. After accounting for the effects of population stratification, effects
of covariates and genotype × sex interactions on the GWAA of RA were assessed by conducting
association and interaction analyses. We found significant allelic associations, covariate, and genotype ×
sex interaction effects on RA. Several top single-nucleotide polymorphisms (SNPs) (~22 SNPs) showed
significant associations with strong p-values (p <1×1 0
-4 - p <1×1 0
-24). Only three SNPs on
chromosomes 4, 13, and 20 were significant after Bonferroni correction, and none of these three SNPs
showed significantgenotype×sex interactions. Ofthe30topSNPswith significant(p<1×10
-4 -p<1×
10
-6) interactions, ~23 SNPs showed additive interactions and ~5 SNPs showed only dominance
interactions. Those SNPs showing significant associations in the regular logistic regression failed to show
significantinteractions.Incontrast,theSNPsthatshowedsignificantinteractionsfailedtoshowsignificant
associations in models that did not incorporate interactions. It is important to consider interactions of
genotype × sex in addition to associations in a GWAA of RA. Furthermore, the association between
SNPs and RA susceptibility varies significantly between men and women.
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Rheumatoid arthritis (RA) is a chronic inflammatory
disease of the joints, of unknown cause. It affects around
2% of people 60 years and older, but occurs in people of
all ages. Women are more susceptible to RA than are
men, and the disease is more frequent in some Native
N o r t hA m e r i c a ng r o u p s[ 1 ] .I n f l a m m a t i o ni nR Ac e n t e r s
on the joints, causing joint swelling, pain, and degrada-
tion of joint cartilage and bone.
Genetic factors influence RA susceptibility [2,3].
Although family and twin studies suggest a genetic
contribution to RA susceptibility of about 50-60%,
causative genetic variants have not been identified
[4,5]. Furthermore, genome-wide linkage studies of
both discrete and continuous traits (RF-IgM and anti-
CCP phenotypes) have shown strong evidence for
linkages with several loci including chromosomes 6
and 18. Moreover, some genetic systems are strongly
linked to disease susceptibility and to the disease
phenotype. Recent association studies have implicated
the HLA region on 6p, which accounts for about 30% of
heritable risk [6]. The most studied gene associated with
joint damage in RA is HLA-DRB1 [7]. However, genes
from non-HLA regions are largely unknown.
Given that genome-wide association analysis (GWAA) is
explicitly designed to detect genetic variants under the
common-disease common-variant (CDCV) model for
complex traits such as RA, it was expected that GWAA
would capture most common genetic variation in RA.
Because RA results from the interplay between an
individual’s genetic background and unknown environ-
mental factors, it is important to assess the effects of
environmental factors and their interactions on RA.
Using Genetic Analysis Workshop (GAW) 16 data, we
assessed the effects of covariates and interactions on the
GWAA of RA. The only such factor available in the
dataset we studied was sex. Although sex is not itself an
environmental factor, it can serve as a model for how
environmental variables and gene × environment inter-
actions could be treated in the GWAA of RA. In addition
to being a strong RA susceptibility factor, there is
published evidence of heterogeneity by sex in the
association of certain genetic systems.
Methods
Subjects
ForthisGAW16analysis,theGAW16RAdata(Problem1)
from the North American Rheumatoid Arthritis Consor-
tium (NARAC) cases (n = 868) and matched controls (n =
1194) have been used. For the NARAC study, patients
were drawn from rheumatology clinics across North
America who were anti-CCP-positive and met the criteria
forRAadoptedbytheAmericanCollegeofRheumatology
in 1987. The NARAC samples (n = 2062) were from
multiplex families in which at least one sibling had
obvious erosions as seen on radiography of the hand, and
atleast onesiblinghad anonsetofRAbetweentheagesof
18 and 60 years.
Genotyping
As described in Padyukov et al., [8] SNP genotyping was
performed at the Feinsterin Institute for Medical
Research Samples according to the Illumina Infinium 2
assay manual (Illumina, San Diego). All cases and most
of the control samples were genotyped with the
HumanHap550k beadchip.
Association analysis
We performed a population-based genome-wide associa-
tion analysis using PLINK, a tool set for whole genome
association [9]. We analyzed GAW16 Problem 1 data
using a variety of analyses: stratification, association, and
interaction analyses using PLINK software [9]. We used
the structured association approach, a simple but power-
ful approach, to detect population stratification, as
implemented in the PLINK software [9-11]. PLINK’s
clustering approach is based on the genome-wide average
proportion of alleles shared identical-by-state (IBS)
between two individuals, i.e., pairing up individuals
based on genetic identity. IBS clustering is used to test
whether two individuals belong to the same population.
Following the stratification analysis, we performed a
standard case-control association test using a Cochran-
Mantel-Haenszel statistic (1 df) that tests for single-
nucleotide polymorphism (SNP)-disease association
conditional on the clustering i.e., accounts for stratifica-
tion effects. We used the most stringent Bonferroni
correction (BONF) as well as the less stringent Benjamini
and Hochberg false discovery rate (BH-FDR) for multiple
testing corrections.
Interaction analysis
The covariates for a discrete trait (RA affection status)
included sex and genotypic models: additive (ADD),
dominant deviation (DD), and general (GM). An
additive model represents the additive effects of SNPs
i.e., the effect of each additional minor allele as
represented by the direction of the regression coefficient.
For example, a positive regression coefficient indicates
that the minor allele increases risk. A DD model
represents a separate test of the dominance component,
and a general model represents the joint test of both
ADD and DD components. However, in contrast to a
dominance model, DD refers to a variable coded in such
a way (0, 1, 0 for three genotypes AA, Aa, aa) that it
represents the dominance deviation from additivity
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n a n to rr e c e s s i v e .E f f e c t so fg e n o t y p e×s e xi n t e r a c t i o n s :
ADD × Sex and DD × Sex were assessed using a logistic
regression approach as implemented in PLINK.
Results
Using RA case status as affected and unaffected, we
performed a general association and genotype × sex
interaction analyses to identify those loci associated with
RA. Given that the NARAC sample was stratified due to
the presence of subpopulations, we performed the
association analyses accounting for the population
stratification. We found significant allelic associations,
covariate (sex), and genotype × sex interaction effects on
RA. The results of the association analyses are presented
in Figure 1 and Table 1. In Figure 1, plot A shows
associations across the entire genome and plot B shows
associations in non-HLA regions. In Table 1, top SNPs
(~22 SNPs with the best SNP on each chromosome) with
strongest p-values (ranging from p <1×1 0
-4 to p <1×
10
-24) were presented along with corrected p-values for
multiple testing, and genotype × sex interaction p-values.
As shown in Table 1, the most strongly associated SNP
(p <1×1 0
-8)i nan o n - H L Ar e g i o nw a so nc h r o m o s o m e
4, rs512244 (p =8 . 3 6 2×1 0
-8). Only three SNPs on
chromosomes 4, 13, and 20s u r v i v e dt h eo v e r l y
conservative Bonferroni correction, and none of these
three SNPs showed significant genotype × sex interac-
tions. Interestingly, the Benjamini and Hochberg’sf a l s e
discovery rate (BHFDR), an alternative multiple testing
correction, also yielded very similar p-values as shown in
Tables 1 and 2.
In the genotype × sex interaction analysis, we identified a
new set of SNPs to be highly significant in the presence of
genotype × sex interaction, which showed no significance
in the allelic association model. In Table 2, top SNPs
showing significant interaction effects were presented along
with corresponding association p-values for comparison.
Out of 30 top SNPs with significant interactions (p <1×
10
-4 to p <1×1 0
-6) shown in Table 2, ~23 SNPs showed
ADD × Sex and ~5 SNPs showed only DD × Sex
interactions. Interestingly, the evidence of significance
was reduced for most of the top SNPs showing association
with RA in Table 1 in the presence of interactions as shown
in Table 2. On the other hand, most of the SNPs showing
highly significant effects of genotype × sex interactions
(Table 2) showed no significant associations with RA
(Table 1). Among covariates, two SNPs (on chromosomes
1 and 10) showed highly significant sex effects (p <1×
10
-4), five SNPs showed additive effects, and two SNPs
showed DD effects (Table 2). The observed differences
between men and women in RA susceptibility may be
attributable to the differences according to sex in their
susceptibility to the disease and in the expression of clinical
phenotype of RA.
Discussion
In this study, we performed a population-based GWAA
and genotype × sex interaction analyses using the
GAW16 RA data (Problem 1) from NARAC. We
performed association analyses without correcting for
population stratification and found interesting associa-
tions (results not shown). Because the NARAC popula-
tions consisted of substructures, we repeated association
Figure 1
Association plot of RA NARAC SNP data with HLA (Plot A) and without HLA (Plot B) regions.
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significant difference in the association results. For
example, in the first association analysis, a SNP
(rs2476601) in the PTPN22 gene, an excellent candidate
gene on chromosome 1 for RA, showed a highly
significant (1.784 × 10
-12) association with RA but the
signal disappeared in the subsequent analysis after
correction for stratification effects (p =4 . 7 4 8×1 0
-4).
Furthermore, majority of the SNPs turned out to be
insignificant after correcting for multiple testing using
the Bonferroni correction, an overly conservative
approach, and the BH-FDR, a less stringent correction
that tolerates more false positives.
Following the main-effects association analysis, we
performed interaction analyses to assess the effects of
covariates and genotype × sex interactions on GWAA of
RA. Sex was the only “environmental” covariate avail-
able to us. Although sex does not reflect environmental
exposure in the traditional sense of a factor external to
the individual, sex does significantly influence a
person’s internal environment in terms of hormonal
actions and the like. Sex may also influence a person’s
exposure to external substances such as hair dyes,
cosmetics, and fragrances. We found significant covari-
ate and interaction effects on RA. Interestingly, SNPs
showing significant main-effects associations did not
show significant interactions. In contrast, the SNPs that
showed the strongest evidence for interactions did not
show significant main-effect associations. This finding
reveals that in a GWAA, it is important to consider
genotype (additive or dominant) by sex interaction
effects on RA in addition to main-effects associations.
Otherwise, such variants may be missed. In other words,
the list of SNPs that would be followed up for
replication or confirmation changes with the genotype ×
sex interaction effects.
On the other hand, SNPs with significant genotype × sex
interaction did not necessarily have a significant (or even
suggestive) main effect association. Therefore, limiting
interaction tests to markers with significant main effects
would likely find different results. We cannot say whether
this would lose power or would protect against false
positives on the basis of these results because the
underlying genetic architecture of RA is largely unknown.
For example, outside of the HLA region, there are
69 p-values of 10
-5 or better for the standard association
analysis, so the top 100 SNPs would certainly be different
if chosen using both standard association and genotype ×
sex interaction. However, genotype × sex interaction
increases the multiple testing problem, and an exceed-
ingly low p-value may be required to be considered
significant after correction. In this study, the association
between SNPs and RA susceptibility varies significantly
between men and women. These results further support
our earlier observation that there was significant hetero-
geneity between men and women, in the susceptibility
and severity effects of HLA-DRB1, men being more
susceptible to this gene system’s influence [12].
Table 1: Genome-wide association of SNPs with RA in NARAC sample, best SNP on each chromosome
Chr SNP Position Minor allele/
major allele
Association
p-value
Allelic OR (95% CI) Bonferroni
adjusted p-
value
BH-false
discovery
rate p-value
Interaction
(ADD × sex)
p-value
1 rs865682 223,080,777 A/G 4.545 × 10
-6 0.39(0.26-0.60) 0.16 0.16 -
2 rs12477038 201,518,282 G/A 1.038 × 10
-5 0.47(0.33-0.66) 0.41 0.25 0.09
3 rs6775137 193,649,851 A/C 2.124 × 10
-5 0.65(0.53-0.79) 0.70 0.70 -
4 rs512244 12,775,151 G/A 8.362 × 10
-8 2.2(1.7-3.0) 0.002 0.002 0.14
5 rs7726943 67,854,337 G/A 2.991 × 10
-6 0.62(0.50-0.76) 0.09 0.09 0.21
6 rs660895 32,685,358 G/A 8.346 × 10
-24 3.4(2.7-4.3) 2.642 × 10
-19 2.642 × 10
-19 5.263 × 10
-45
7 rs17470799 100,768,534 A/G 6.937 × 10
-6 0.4(0.27-0.60) 0.18 0.12 1.0
8 rs966561 6,642,801 A/G 6.817 × 10
-5 0.68(0.56-0.82) 1.0 0.54 0.93
9 rs306772 121,171,909 A/G 3.559 × 10
-5 1.7(1.3-2.1) 0.83 0.40 0.09
10 rs7072006 133,595,618 A/G 5.309 × 10
-6 0.48(0.35-0.67) 0.13 0.13 0.78
11 rs761453 31,834,576 A/G 3.867 × 10
-5 0.61(0.48-0.77) 0.91 0.46 0.52
12 rs2283275 2,054,821 G/A 4.362 × 10
-6 0.59(0.47-0.74) 0.10 0.10 0.98
13 rs17086849 28,064,399 A/G 3.158 × 10
-6 0.56(0.44-0.72) 0.06 0.06 0.94
14 rs12885166 92,195,035 A/C 1.139 × 10
-5 1.6(1.3-1.9) 0.18 0.18 0.45
15 rs11857639 71,424,825 A/G 1.083 × 10
-5 0.39(0.25-0.61) 0.16 0.16 1.0
16 rs1076251 73,326,313 A/C 6.524 × 10
-6 0.59(0.46-0.74) 0.10 0.10 0.21
17 rs1039519 3,394,664 G/A 7.11 × 10
-5 1.52(1.2-1.9) 0.90 0.60 -
18 rs2174899 72,420,808 G/A 3.671 × 10
-5 0.57(0.44-0.75) 0.54 0.54 -
19 rs9630874 57,619,851 A/C 1.27 × 10
-5 0.31(0.17-0.54) 0.10 0.10 0.51
20 rs1182531 57,826,397 A/C 4.314
-6 0.56(0.43-0.71) 0.05 0.05 0.17
21 rs12626622 31,981,460 A/G 2.063 × 10
-4 1.8(1.3-2.4) 1.0 0.52 0.20
22 rs3830104 35,033,124 G/A 3.974 × 10
-5 2.3(1.5-3.5) 0.29 0.21 0.73
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This case-control GWAA has yielded genomic regions
exhibiting significantly different genotype frequencies
between cases and controls that may contain genetic
variants that predispose to RA and the regions identified
may differ in the analyses with and without interactions.
Our findings suggest that the association between SNPs
and RA susceptibility varies significantly between men
and women. In this GWAA of RA, characterization of
how genes and the environment interact is important
because the effects of covariates and genotype × sex
interactions on RA are significant. Similar tests for
interaction with sex and other environmental variables
should be included in future case-control design GWAA
in RA. Our study also emphasizes the importance of
accounting for population stratification in analyzing
GWAS data. Simple IBS-based cluster analysis changed
the outcome of the analysis substantially for some
markers by accounting for the effects of stratification
due to the presence of subpopulations.
List of abbreviations used
ADD: Additive; BH-FDR: Benjamini and Hochberg false
discovery rate; BONF: Bonferroni correction; CDCV:
Common-disease common-variant; DD: Dominant
deviation; GAW: Genetic Analysis Workshop; GM:
General; GWAA: Genome-wide association analysis;
IBS: Identical-by-state; NARAC: North American Rheu-
matoid Arthritis Consortium; RA: Rheumatoid arthritis;
SNP: Single-nucleotide polymorphism.
Competing interests
The authors declare that they have no competing
interests.
Authors’ contributions
RA conceived of the study, participated in its design,
performed the statistical analyses including genome-wide
association and interaction analysis and interpretation of
results, and drafted the manuscript. EH participated in the
statistical analysis. IDR participated in study design,
Table 2: Covariate and genotype × sex interaction effects on RA in NARAC sample
p-Value
Chr SNP Position Unadj Bonferroni BH-
FDR
Sex ADD DD General
model
ADD × Sex DD × Sex
1 rs9729157 19,363,907 0.88 1.0 0.99 0.6 0.09 0.91 0.23 3.029 × 10
-4 0.02
1 rs11211044 44,987,845 0.03 1.0 0.82 4.614 × 10
-4 0.17 0.02 0.004 0.86 7.327 × 10
-5
2 rs280734 35,016,040 0.96 1.0 0.99 0.02 0.03 0.20 0.06 6.828 × 10
-5 0.04
2 rs4953717 43,186,551 0.96 1.0 0.99 0.65 0.47 0.01 0.02 0.02 8.957 × 10
-6
3 rs1391769 69,656,092 0.96 1.0 0.98 0.01 0.02 0.31 0.06 7.111 × 10
-5 0.04
3 rs17032482 1,045,039 0.46 1.0 0.97 0.61 0.05 1.752 × 10
-4 4.623 × 10
-4 0.15 1.239 × 10
-4
4 rs6811287 9,857,092 0.13 1.0 0.95 0.003 0.02 0.63 0.04 6.938 × 10
-6 0.10
4 rs12646171 24,755,192 0.38 1.0 0.97 0.38 0.99 0.12 0.25 0.26 7.627 × 10
-5
5 rs7725288 36,364,063 0.85 1.0 0.99 0.003 0.02 0.54 0.04 2.19 × 10
-6 0.688
5 rs6595726 126,044,143 0.44 1.0 0.97 0.049 0.13 0.02 0.04 0.2027 1.234 × 10
-4
6 rs493871 33,673,452 0.60 1.0 0.98 0.008 0.02 0.92 0.08 1.989 × 10
-5 0.64
6 rs1023107 14,138,449 0.74 1.0 0.98 0.54 0.16 0.019 0.06 6.545 × 10
-4 3.56 × 10
-4
7 rs12718890 54,528,684 0.96 1.0 0.98 0.009 0.07 0.13 0.11 1.146 × 10
-4 0.12
8 rs10090327 87,115,021 0.75 1.0 0.99 0.02 0.05 0.35 0.15 5.127 × 10
-5 0.02
8 rs4873802 144,691,998 0.11 1.0 0.98 0.62 0.02 1.956 × 10
-6 8.096 × 10
-6 0.008 0.07
9 rs1413334 80,148,584 0.43 1.0 0.96 0.57 0.004 0.005 0.007 1.319 × 10
-4 0.03
9 rs10738881 32,153,679 0.09 1.0 0.88 0.67 9.614 × 10
-5 0.02 4.968 × 10
-4 0.002 5.619 × 10
-5
10 rs12412942 2,347,702 0.05 1.0 0.84 1.277 × 10
-4 3.007 × 10
-4 0.9816 8.523 × 10
-4 3.414 × 10
-4 0.42
11 rs1528648 14,096,262 0.66 1.0 0.99 0.006 0.08 0.13 0.16 1.219 × 10
-4 0.17
12 rs6539583 75,591,349 0.36 1.0 0.95 0.24 0.18 0.34 0.36 7.358 × 10
-5 0.07
13 rs1773126 46,123,327 0.26 1.0 0.96 0.02 0.10 0.74 0.21 1.307 × 10
-4 0.80
14 rs4294750 104,034,158 0.35 1.0 0.95 0.30 6.582 × 10
-4 0.10 0.002 8.144 × 10
-5 0.06
15 rs2472297 72,814,933 0.20 1.0 0.92 0.87 4.194 × 10
-6 0.04 1.389 × 10
-5 2.078 × 10
-4 0.006
16 rs12934235 5,637,396 0.62 1.0 0.98 0.02 0.33 0.64 0.23 8.075 × 10
-4 0.11
17 rs225218 27,923,447 0.92 1.0 0.99 0.003 0.17 0.33 0.21 9.103 × 10
-6 0.42
18 rs906283 10,918,707 0.15 1.0 0.99 0.008 9.993 × 10
-4 0.24 0.002 9.886 × 10
-5 0.36
19 rs12151188 44,147,374 0.40 1.0 0.96 0.75 0.01 0.78 0.03 7.579 × 10
-4 0.03
20 rs6030315 35,003,238 0.96 1.0 0.99 0.20 0.03 0.76 0.11 6.594 × 10
-5 0.15
21 rs991985 38,128,024 0.66 1.0 0.99 0.002 0.10 0.33 0.05 1.996 × 10
-4 0.59
22 rs2880494 26,206,836 0.92 1.0 0.99 0.605 0.11 0.58 0.28 2.832 × 10
-4 0.02
aChr, chromosome; Unadj, Unadjusted p-values for main-effects association.
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